Claxton, L., Malcolm, B., Taylor, M., Haig, J., & Leteneux, C. (2014). Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK. Springer International Publishing.

Claxton, Lindsay, Bill Malcolm, Matthew Taylor, Jennifer Haig, and Claudia Leteneux. Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK. Springer International Publishing, 2014.

Claxton, Lindsay, et al. Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK. Springer International Publishing, 2014.